MedPath

HEPCIDIN LEVELS IN IRON DEFICIENCY ANEMIA IN CHILDRE

Phase 4
Conditions
Health Condition 1: null- Case: Anemic children aged 6-59 months with Hb 11 g/dL and serum ferritin 12 µg/L and/or transferrin saturation 16%. Control: Age-matched non-anemic healthy children with Hb � 11 g/dL.
Registration Number
CTRI/2016/08/007189
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Anemic children aged 6-59 months with Hb <11 g/dL and serum ferritin < 12 µg/L and/or transferrin saturation <16%.

Exclusion Criteria

Concomitant infection (ascertained on history) and CRP positive, chronic illness (renal, liver, infectious, hematological, inflammatory disease), recent (within 3 months) blood transfusion, children receiving hematinics/micronutrient supplements, any malignant disease and MCV > 100 fL.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum and urinary hepcidin levelsTimepoint: Baseline
Secondary Outcome Measures
NameTimeMethod
<br/ ><br>Secondary <br/ ><br>Change in serum and urinary hepcidin levels after 3 months of treatment for iron deficiency anemia.Timepoint: At 3 months following enrolment
© Copyright 2025. All Rights Reserved by MedPath